| Dr Joel N/a Ringold, MD | |
|
3500 W. Lomita Blvd, Ste 305, Torrance, CA 90505-5021 | |
| (310) 539-6040 | |
| (310) 539-7307 |
| Full Name | Dr Joel N/a Ringold |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 3500 W. Lomita Blvd, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588660955 | NPI | - | NPPES |
| 00G102610 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | G10261 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel N/a Ringold, MD 3500 W. Lomita Blvd, Ste 305, Torrance, CA 90505-5021 Ph: (310) 539-6040 | Dr Joel N/a Ringold, MD 3500 W. Lomita Blvd, Ste 305, Torrance, CA 90505-5021 Ph: (310) 539-6040 |
News Archive
The Consumer Healthcare Products Association (CHPA) today applauded Ohio Governor John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Representative Terry Johnson (R-Portsmouth) and Representative Danny Bupb (R-West Union). With the new law, Ohio now becomes the 25th state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx).
College students who consider dropping out are particularly sensitive to a handful of critical events including depression and loss of financial aid, according to a study led by Michigan State University scholars.
Over 3,500 Australians were hospitalised due to contact with a venomous animal or plant in 2017–18, according to a new report released today by the Australian Institute of Health and Welfare (AIHW).
People who use snus run twice the risk of developing alcohol dependency compared with non-users, and the more one uses snus, the higher the risk. This has been found in a study from Umeå University which was published in the journal Drug and Alcohol Dependence.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex."
› Verified 3 days ago
Deborah Chon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 100, Torrance, CA 90505 Phone: 310-542-6333 | |
Erika Joyce Kalash, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3565 Del Amo Blvd, Torrance, CA 90503 Phone: 310-214-0811 | |
Hosayn Khaleeli, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2245 Sepulveda Blvd, Torrance, CA 90501 Phone: 310-320-3204 Fax: 310-320-0919 | |
Mr. Anthony C Dike, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 20280 S Vermont Ave Ste 215, Torrance, CA 90502 Phone: 323-434-4626 Fax: 310-693-8082 | |
Paul J Brown, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3333 Skypark Dr, Torrance, CA 90505 Phone: 310-517-9006 | |
Dr. Philip W Chung, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2841 Lomita Blvd 215, Torrance, CA 90505 Phone: 310-379-2860 Fax: 310-325-1144 | |
Dr. Diane Jennifer Prager, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3445 Pacific Coast Hwy Ste 300, Torrance, CA 90505 Phone: 310-325-8252 |